Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

COVID-19 Report for Life Sciences and Health Care Companies

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

News

Buy American EO applies domestic preferences for "essential medicines" and "medical countermeasures"

On August 6, 2020, U.S. President Donald Trump issued his much-anticipated "Buy American" Executive Order (EO), intended to increase and support domestic manufacture and Federal...

News

COVID-19 Report for Life Sciences and Health Care Companies (3 - 7 August 2020)

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

Hogan Lovells Publications

Podcast: Talking the cure

Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting edge topics such as...

News

COVID-19 Report for Life Sciences and Health Care Companies (27 - 31 July 2020)

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

News

FDA proposes annual summary reporting requirements for Right to Try drug sponsors, manufacturers

On July 23, the U.S. Food and Drug Administration (FDA) announced a new proposed rule that would require sponsors and manufacturers who provide an ‘‘eligible investigational...

News

COVID-19 Report for Life Sciences and Health Care Companies (20 - 24 July 2020)

The COVID-19 Report is a compilation of coronavirusnews, analysis, and insightsfrom around the worldto helplife sciences and health care companies stay current in...

News

FDA extends enforcement discretion period for regenerative medicines, citing COVID-19 challenges

Today, the U.S. Food and Drug Administration (FDA) extended the enforcement discretion period for certain human cell, tissue, and cellular and tissue-based products (HCT/Ps) by an...

News

Assignment of Health Care Receivables to Italian SPVs – need of acceptance by the debtor

The Italian Parliament has converted into Law the Italian Law Decree No. 34 of 19 May 2020 (the "Rilancio Decree"). The law of conversion of the Rilancio Decree was published on...

Loading data